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Purpose/Objective: International research indicates that oncology 
care workers are exposed to a variety of unique occupational stressors 
that put them at significant risk of burnout. This has severe 
implications for job satisfaction, the retention of staff and arguably 
the quality of care cancer patients receive whilst on treatment. The 
current study aimed to obtain a national indication of stress 
associated with occupational stressors, burnout and job satisfaction 
within New Zealand (NZ) Radiation Therapy departments. Potential 
indicators of burnout and job satisfaction were explored, as well as 
job satisfaction initiatives. 
Materials and Methods: All staff currently practicing in the eight 
Radiation Therapy departments in NZ were invited to participate 
anonymously in a questionnaire hosted on SurveyMonkey via email. 
The questionnaire contained questions addressing participant 
characteristics, such as age, work experience and position. The 
Maslach Burnout Inventory (MBI) was incorporated in order to make 
direct comparisons with previously published studies, and scales 
measuring the intensity of stress associated with specific occupational 
stressors, stress reduction strategies and job satisfaction were 
included. Incomplete responses were excluded and a total of 171 (out 
of 349) complete responses were analysed with SPSS 19.  
Results: Of the 171 responses, 23 identified as oncologists (Os), 111 
identified as radiation therapists (RTs), 22 identified as radiation 
nurses (RNs) and 15 identified as radiation physicists (RPs).  
All participants, regardless of profession, reported high stress levels 
associated with both patient-centred and organisational stressors. 
Participants scored high in all three domains of burnout: emotional 
exhaustion, depersonalisation and personal accomplishment. 
Interestingly, although organisational stressors and emotional 
exhaustion predicted lower job satisfaction, patient stressors were 
associated with higher job satisfaction. Job satisfaction initiatives 
such as on-going education, mentoring and role extension were 
supported by many participants as was addressing organisational 
stressors, such as lack of recognition and support from management 
and unrealistic expectations and demands. 
Conclusions: Staff in NZ exhibit higher levels of burnout than MBI 
medical norms and international studies conducted in Europe, North 
America and Australia. In contrast to previous studies, indications of 
personal accomplishment and job satisfaction were incredibly high. In 
NZ staff in Radiation Therapy departments may be more at risk of 
compromising their wellbeing, compelled by the sense of personal 
accomplishment and satisfaction they derive from their chosen 
profession. 
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Purpose/Objective: Head and neck (HN) radiotherapy within the 
Danish Head and Neck Cancer Group (DAHANCA) has changed in the 
last decade from 3D conformal radiotherapy to exclusively intensity 
modulated radiation therapy (IMRT). The steep 3D dose gradients in 
IMRT call for a high geometric and dosimetric accuracy in the entire 
chain from treatment planning to treatment delivery. The purpose of 
the DAHANCA RT-QA group is to monitor the quality of the IMRT 
delivery at all six radiotherapy departments participating in DAHANCA 
protocols. The geometric and dosimetric accuracy of the IMRT delivery 
was verified by means of an external, independent dose audit. 
Materials and Methods: The M. D. Anderson Phantom Lab (MDAPL) of 
the M. D. Anderson Cancer Center provided each DAHANCA center 
with an anthropomorphic HN phantom equipped with Thermo-
luminescence Dosimeters (TLD) and radiochromic films [A. Molineu, 
IJROBP 2005]. At each center, the phantom went through the standard 
clinical treatment chain similar to an actual patient, i.e. CT scan, 
treatment planning, and treatment delivery including cone beam-CT 
or kV image setup. Three centers used sliding window IMRT technique, 
two centers used segmental step and shoot IMRT technique and one 
center used volumetric modulated arc therapy technique (VMAT). 
According to MDAPL, the treatment planning should follow RTOG 
protocols where at least 95 % of the target must receive the 
prescribed dose. The DAHANCA guidelines, which adheres to ICRU, 
states that at least 95 % of the prescribed dose should be delivered to 
the entire target.This difference made the dose planning non standard 
for the centers. The films were analysed by gamma evaluation and the 
TLD measured doses were compared to the doses reported by the 
planning systems. 
Results: All centers met the MDAPL pass criteria of 85 % with gamma 
criteria of 7 % and 4 mm. The average pass rate for axial and sagittal 
films were 99.6 % (range 99-100 %) and 99.2 % (97-100 %), 
respectively. Using a more strict gamma criteria of 3 % and 3 mm, the 
average pass rates for the axial and sagittal films were 93 % (86-99 %) 
and 89 % (83-96 %), respectively. The average ratio of the measured 
RCP TLD doses to reported doses was 0.99±0.016(1SD) across the 
centers. The average displacement of the steepest dose gradient 
between primary PTV and organ at risk was 0.7 mm (0-2 mm). 
Conclusions: All 6 centers in DAHANCA passed the external dose 
audit. The analyses showed a high correlation between treatment plan 
and treatment delivery, indicating high and consistent quality of the 
IMRT delivered in the DAHANCA centers. 
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Purpose/Objective: To assess efficacy of planning QA for the ART 
DECO trial (CRUK/10/018) and identify any significant differences 
between static (sIMRT) and rotational (rIMRT) forms of IMRT in the 
trial. 
Materials and Methods: A randomised multicentre accelerated 
radiotherapy study of dose escalated IMRT vs. standard dose IMRT in 
patients receiving treatment for locally advanced 
laryngeal/hypopharyngeal cancers (ART DECO) is currently recruiting. 
The experimental arm of 67.2Gy/28 fractions to the radical target 
(PTV1) and 56Gy/28 fractions to the elective target (PTV2) is being 
tested against a UK standard of 65Gy/30fractions to PTV1 and 
54Gy/30fractions to PTV2. 
As part of the UK RTTQA IMRT credentialing program, the QA team 
reviews a hypopharynx test case planned by the centre at the 
experimental dose level for each planning system and delivery 
technique used. Non-compliant or sub-optimal plans require 
resubmission. Evaluations have been carried out on PTVs edited back 
from the skin surface. Local CTV-PTV and OAR-PRV margins were 
used. 
Results: To date, there have been 32 protocol compliant hypopharynx 
submissions from 27 centres; 14 using rIMRT and 18 sIMRT. 
Table 1 shows differences between the initial and approved plans for 
each centre. PTV1 coverage improved based on all DVH criteria 
investigated. PTV1 D5% improved, whilst no change was seen in 
D2%.PTV2 showed a statistically significant improvement at D95% and no 
degradations. 
There was an overall increase in dose to the brainstem (BS) and spinal 
cord (SC) PRVs at theD1cm3 level, all approved plans were within the 
tolerance of 55Gy and 48Gy respectively. No statistically significant 
changes were seen in all other constraints. 74% of plans met the 24Gy 
contralateral mean dose constraint in their final submission. 
In terms of target coverage, sIMRT and rIMRT plans were comparable. 
There were statistically significant differences at the PTV1 D50%, D5% 
and D2%,with rIMRT techniques being lower on average by 0.2Gy 
(p=0.014), 0.8Gy (p<0.001)and 0.6Gy (p=0.009) respectively. BS Dmax 
and BS PRV D1cm3were the only OAR or PRV constraints showing 
statistically significant differences,being on average 5.0Gy (p=0.046) 
and 5.1Gy (p=0.026) lower in the rIMRT plans. 
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Conclusions: The QA process resulted in protocol compliant plans, 
generally improving based on the investigated criteria. The lack of 
differences in target coverage between sIMRT and rIMRT plans may 
partly be a result of the QA process ensuring comparability across the 
trial, however the more homogeneous dose distributions resulting 
from the rIMRT requires further investigation. 
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Purpose/Objective: To develop an analysis method for pretreatment 
verification based on the MLC leaf opening times (LOTs) measured 
with the imaging detector of the tomotherapy system. 
Materials and Methods: Twenty-five treatments from two 
tomotherapy units were delivered and acquired by the imaging 
detector of the system. Based on the fluence measured in the 
detector, LOTs of each treatment were extracted. 
LOTs at each gantry angle were summed taking into account the 
position of the beam at each projection calculated from treatment 
parameters such us field width and pitch, leading to a composite 
fluence map at each of the 51 gantry angles in which the tomotherapy 
system divides a rotation. These fluence maps have time units, and 
allow for analysis methods similar to those of field-by-field 
pretreatment verification. 
Mean differences in time between planned and delivered fluences, as 
well as standard deviation of that error distributions were obtained. 
Percentages of points within a 1%, 2%, 3% and 5% of the mean time of 
each treatment were also used in the analysis. 
These parameters were compared with conventional pretreatment 
verification methods on a cylindrical virtual water phantom. 
Results: Mean results of both machines are shown in the table, results 
show a good performance of both tomotherapy systems. Mean time 
errors lie within a 1% in all of the cases with standard deviations 
within a 3%. Those small differences in mean time errors suggest that 
important differences in dose are not caused by the MLC.  
Employing a 90 % of passing points as a threshold value for the 5% test 
would imply that only two of the treatments would have been 
rejected, while almost half of the treatments would have been 
rejected with the 3% criterion. Nevertheless, all of the treatments 
passed the verification based on ionization chamber and film. 
Therefore, the percentage of points within a 5% appears to be a good 
criterion for pretreatment verification, as it yields results similar to 
those obtained with our actual method based on the gamma index. 
No correlation was found between the results of the gamma index 
with those of fluence per angle. Gamma index results depend more on 
parameters such us treatment volume or shape of the dose 
distribution, while fluence results are more related with projection 
time and mean LOTs. 
 
 Mean values 
Tomotherapy 
1 
Tomotherapy 
2 
Cylindrical phantom 
verification 
Dose difference 
(%) -0,9 0,1 
% passing Gamma 
(3% 3mm) 99,3 98,1 
Imaging detector 
verification 
Time error (%) 0,4 0,2 
St. dev. of time 2,1 1,8 
error (%) 
% of points within 
1% 45,6 54,1 
% of points within 
2% 71,2 79,6 
% of points within 
3% 84,8 90,6 
% of points within 
5% 95,7 97,7 
 
Conclusions: A method for pretreatment verification based on fluence 
measurements with the on-board imaging detector was analyzed. The 
percentage of points within a 5% of the mean fluence time seems to 
be the more appropriate index for pretreatment verification. 
Nevertheless, treatments that passed the verification with 
conventional methods failed the proposed index. Therefore,further 
analysis on this matter should be developed.  
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Purpose/Objective: Complement existing EPID-based QA procedures 
for linear accelerators with specific VMAT tests covering the 
additional involved elements: dynamic MLC, dose modulation, gantry 
speed modulation and dose delivery during gantry rotation. 
Materials and Methods: Four different MLC types were used in this 
study: Varian Millennium™120MLC & HD120™MLC, and Elekta MLCi2 & 
Beam Modulator™. Tests criterions described in the commissioning 
procedure proposed by Ling et al. [Ling2008] were adapted 
- Test 1: leaf positions test using picket fence (PF) patter acquired at 
different gantry angles and during gantry rotation. 
- Test 2: variation of dose rate and gantry speed during gantry 
rotation. 
- Test 3: variation of dose rate and MLC leaf speed during gantry 
rotation. 
Some adaptations were done in order to take into account the 
differences in capabilities and geometry between the MLCs and 
accelerators, as well as to use EPID instead of films. On Varian Linacs, 
the EPID acquisition was done using fields of the DICOM RT Plans 
provided by the manufacturer. On Elekta Linacs it was done using the 
iComCAT software. The analysis of acquired EPID images was 
performed automatically using ARTISCAN (software solution developed 
by AQUILAB SAS, France). 
Results: All the key elements were correctly automatically detected 
in EPID images of all devices, regardless of the problems impacting 
image quality (Noise, Flexmap…). 
Test 1 was analyzed on 3 criterions for each slit of the PF: position of 
slit center, FWHM of the slit and dose delivered in the slit. In all the 
cases, every slit was correctly detected. The evaluation of the slit 
center position was sensitive enough to detect offset as small as 
0.5mm. The delivered dose was also a good indicator of leaf position 
errors. However, FWHM is not a good indicator as it did not correlate 
with induced width changes of the PF. 
Test 2 showed good homogeneity of the delivered dose regardless of 
the gantry speed or the dose rate on all devices. However, for close-
to-maximum gantry speed, slight dose rate fluctuations can occur. 
Test 3 showed a good homogeneity of the dose delivered on Varian 
devices. On the Elekta Beam Modulator, images showed lower 
delivered dose on the left and right borders of the test pattern. 
Repeated occurrences of test 2 and 3 over multiple days showed 
consistency of the results over time. 
Conclusions: Criterions tested in the Ling et al. commissioning 
procedure are as relevant for VMAT-capable Elekta linacs as they are 
for RapidArc-capable Varian linacs. The use of an automated solution 
to analyze EPID images ensures an objective, quantitative, as well as 
fast analysis for QA. However these criterions do not cover all the 
potential sources of error and additional tests will be evaluated. 
[Ling2008] Ling et al. 'Commissioning and quality assurance of 
RapidArc radiotherapy delivery system.' IJROBP 72.2 (2008): 575-581. 
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